Tag: Medicine
-
Study Finds Antidiabetic Drug Effective for Weight-Loss
Tirzepatide, an antidiabetic drug, was found to be effective in helping individuals who are overweight or have obesity and without diabetes lose weight in combination with other lifestyle changes, according to a recent clinical trial published in Nature Medicine.
-
Improving Nanotherapeutic Vaccine Delivery
Northwestern Medicine scientists have developed a more effective way of creating nanotherapeutic vaccines and medicines, according to a study published in ACS Nano.
-
Developing New Approaches for Spinal Cord Injury
Northwestern Medicine scientists have developed a molecular “scaffold” capable of enhancing electrical activity and growth in neurons, which may prove useful in treating spinal cord injuries, per results published in ACS Nano.
-
Combining Immunotherapy and Radiation in Soft Tissue Sarcoma
Combining immunotherapy with radiation may be a promising treatment option for patients with advanced soft tissue sarcoma, according to the results of a Northwestern Medicine clinical trial published in JAMA Oncology.
-
Investigating the Role of DNA Damage in Cardiac Hypertrophy
A novel cellular pathway regulates DNA damage and structural changes in cardiomyocytes which contributes to the development of cardiac hypertrophy according to a Northwestern Medicine study published in Circulation.
-
Weight Loss Drug May Help Patients with Heart Failure
The antidiabetic and weight loss drug semaglutide, sold under the brand names Ozempic and Wegovy, can also help patients with heart failure and obesity lose weight while also improving symptoms and increasing exercise capacity, according to a clinical trial published in the New England Journal of Medicine.
-
Investigating the Link Between Iron Deficiency and Regulation of Cell Growth
Northwestern Medicine investigators have uncovered new mechanisms by which iron deficiency inhibits cell growth and proliferation in eukaryotic cells, findings that could improve the understanding of cancer growth and the development of targeted cancer therapies.
-
Combination Immunotherapy Shows No Additional Benefit for Most Advanced Cancers
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern Medicine meta-analysis published in JAMA Oncology.
-
First Device to Monitor Transplanted Organs, Detect Early Signs of Rejection
Northwestern University investigators have developed the first electronic device for continuously monitoring the health of transplanted organs in real time.
-
Study Discovers Novel Therapeutic Target for Acute Respiratory Distress Syndrome
A new Northwestern Medicine study has discovered a novel therapeutic target and therapeutic agents for older patients with acute respiratory distress syndrome, according to recent findings published in Science Translational Medicine.
